Methodological pitfalls in serum IgG2 level measurements by immunoenzymatic assays with monoclonal antibodies

Four anti‐IgG2 monoclonal antibodies (Mabs) were evaluated for their reactivity with purified myeloma IgG2 of different light chain types and Gm allotypes in three distinct immunoenzymatic assays (ELISA). The reactivity of three Mabs with solid‐phase antigens was similar whereas an anti‐Fab antibody...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical laboratory analysis 1992, Vol.6 (1), p.12-16
Hauptverfasser: Aucouturier, Pierre, Lacombe, Corinne, Preud'homme, Jean-Louis
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Four anti‐IgG2 monoclonal antibodies (Mabs) were evaluated for their reactivity with purified myeloma IgG2 of different light chain types and Gm allotypes in three distinct immunoenzymatic assays (ELISA). The reactivity of three Mabs with solid‐phase antigens was similar whereas an anti‐Fab antibody (clone HP 6114) predominantly bound IgG2k. In competitive and immunometric (sandwich type) assays, the binding of the two anti‐IgG2 Mabs (HP 6014 and HP 6114) reacting with epitopes located on the Fab fragment was strongly influenced by the light chain type of IgG2 and by other factors (probably including differences in the variable regions): the Mab HP 6114 reacted virtually only with IgG2k whereas the Mab HP 6014 displayed a much stronger affinity for IgG2λ than for IgG2k; for both anti‐Fab Mabs, important differences were found in their binding to individual IgG2 proteins. In addition, the Mab HP 6014 seemed to show a slightly better affinity for IgG2 bearing the Gm(23) allotype. These results urge much caution in IgG2 level measurement, especially with commerical kits, most of which use the Mab 6014 as the single anti‐IgG2 reagent.
ISSN:0887-8013
1098-2825
DOI:10.1002/jcla.1860060104